Incidence of pertussis in persons ≤15 years of age in Valencia, Spain: Seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults

Journal of Infection

Volumn 49, Issue 3, 2004, Pages 242-247

  Diez Domingo, Javier ^a   Ballester, Alfredo ^a   Baldó, José María ^a   Planelles, María Victoria ^a   Villarroya, José V ^a   Alvarez, Trinidad ^a   Carmen Peidro M ^a   Calero, Pura ^a   Garcés, María D ^a   Sorribes, Ignacio ^a   Graullera, Marta ^a   Jubert, Angels ^a   San Martín, María ^b   González, Antonio ^b  

^a Vaccine Institute of Valencia   (Spain)

^b AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

Author keywords

Epidemiology; Spain; Whooping cough

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PERTUSSIS TOXIN; TOXIN ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; BORDETELLA PERTUSSIS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNITY; IMMUNIZATION; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PARENT; PEDIATRIC HOSPITAL; PERTUSSIS; PROSPECTIVE STUDY; QUESTIONNAIRE; SEROPREVALENCE; SPAIN; SYMPTOMATOLOGY;

ADOLESCENT; AGE DISTRIBUTION; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; PERTUSSIS TOXIN; SEROEPIDEMIOLOGIC STUDIES; SPAIN; WHOOPING COUGH;

EID: 4444339909     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2004.03.003     Document Type: Article

References (38)

1. National Institute of Health, National Institute of Allergy and Infectious Diseases. Respiratory infections. In: The Jordan report 20th anniversary. Accelerated development of vaccines 2002. p. 137-139
2. Taranger J. Trollfors B. Bergfors E. et al. Mass vaccination of children with pertussis toxoid decreased incidence in both vaccinated and nonvaccinated persons Clin Infect Dis 33 2001 1004-1009
3. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence form a 10 year community study BMJ 296 1988 612-614
4. Instituto de Salud Carlos III. Ministerio de Sanidad y Consumo Incidencia de las enfermedades transmisibles de declaración obligatoria. Casos y tasas por 100.000 habitantes a nivel provincial/CC.AA Bol Epidemiol Sem 10 2000 106-107
5. Instituto de Salud Carlos III. Ministerio de Sanidad y Consumo Incidencia de las enfermedades transmisibles de declaración obligatoria. Casos y tasas por 100.000 habitantes a nivel provincial/CC.AA. España Bol Epidemiol Sem 6 2001 55-56
6. Black S. Epidemiology of pertussis Pediatr Infect Dis 16 Suppl. 1997 85-89
7. Campbell P.B. Masters P.L. Rohwedder E. Whooping cough diagnosis: a clinical evaluation of complementing culture and immunofluorescence with enzyme-linked immunosorbent assay of pertussis immunoglobulin A in nasopharyngeal secretions J Med Microbiol 27 1988 247-254
8. Gustafsson I. Hallander H.O. Olin P. Reizenstein E. Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular and a whole-cell pertussis vaccine N Engl J Med 334 1996 349-355
9. Greco D. Salamso S. Mastrantonio P. Giuliano M. Tozzi A.E. Anemona A. et al. A controlled trial of two acellular and one whole-cell bacines against pertussis N Engl J Med 334 1996 341-348
10. Sanz J.C. Fernández M. Sagues M.J. Ramírez R. Castañedad R. Barranco D. et al. Comparación de tres técnicas ELISA para evaluar la seroprevalencia de IgG frente a Bordetella pertussis en niños vacunados con tres dosis de DTPe Enferm Infecc Microbiol Clin 20 2002 10-15
11. Long S.S. Welkon C.J. Clark J.L. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology J Infect Dis 161 1990 480-486
12. Mink C.M. Cherry J.D. Christenson P. et al. A search for Bordetella pertussis infection in university students Clin Infect Dis 14 1992 464-471
13. Robertson P.W. Goldberg H. Jarvie B.H. Smith D.D. Whybin L.R. Bordetella pertussis infection Med J Aust 147 1987 522-525
14. Steketee R.W. Burstyn D.G. Wassilak S.G.F. et al. A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the development disabled J Infect Dis 157 1988 441-449
15. Patriarca P.A. Biellik R.J. Sanden G. et al. Sensitivity and specificity of clinical case definitions for pertussis Am J Public Health 78 1988 833-836
16. Addiss D.G. Davis J.P. Meade B.D. et al. A pertussis outbreak in a Wisconsin nursing home J Infect Dis 164 1991 704-710
17. Cromer B.A. Coydos J. Hackell J. Mezzatesta J. Dekker C. Mortimer E.A. Unrecognized pertussis infection in adolescents Am J Dis Child 147 1993 575-577
18. Miller E. Fleming D.M. Ashworth L.A.E. Mabbett D.A. Vurdien J.E. Elliott T.S.J. Serological evidence of pertussis in patients presenting with cough in general practice in Birmingham Commun Dis Public Health 3 2000 132-134
19. Koster K. Riffelman M. Dohrn B. Wirsing von Konig C.H.G. Comparison of five commercial Enzyme-Linked Immunosorbent Assays for detection of antibodies to Bordetella pertussis Clin Diagnost Lab Immunol 7 2000 422-426
20. Granstrom M. Granstrom G. Serological correlates in whooping cough Vaccine 11 1993 445-448
21. Granstrom G. Wretlind B. Salenstedt C.R. Granstrom M. Evaluation of sereological assays for diagnosis of whooping cough J Clin Microbiol 1988 1818-1823
22. Favereau F, and Associates, editors. Healthcare handbook, vol. 4.2. Spain 1998-1999. Lagon, France 1998:51-124
23. Grupo de trabajo sobre tos ferina. Tos ferina en España: aproximación a la incidencia de la enfermedad y a los efectos de la vacunación en adolescentes y adultos. Enfermedades vacunables. Centro Nacional de Epidemiología. Instituto de Salud Carlos III. Ministerio de Sanidad y Consumo, 2001. http://www.isciii.es/publico/drvisapi.dll?MIval=cw_usr_view_ Folder&ID=53
24. Strebel P. Nordin J. Edwards K. Hunt J. Besser J. Burns S. et al. Population-based incidence of pertussis among adolescents and adults, Minesota, 1995-1996 J Infect Dis 183 2001 1353-1359
25. Wortis N. Strebel P.M. Wharton M. Bardenheir B. Hardy R.B. Pertussis deaths: report of 23 cases in the United States, 1992 and 1993 Pediatrics 97 1996 607-612
26. De Serres G. Shadmani R. Duval B. et al. Morbidity of pertussis in adolescents and adults J Infect Dis 182 2000 174-179
27. de Melker H.E. Schellekens J.F.P. Neppelenbroek S.E. Mooi F.R. Rumke H.C. Conyn-van Spaendonck M.A.E. Reemergence of pertussis in the highly vaccinated population of The Netherlands: observations on surveillance data Emerg Infect Dis 6 2000 348-357
28. Hewlett E.L. Foretell species in: Mandell G.L. Bennett J.E. Dolin R. eds. Principles and practices of infectious diseases 4th ed 1995 2078-2084 Churchill Livingstone New York
29. Pittman M. The concept of pertussis as a toxin-mediated disease Pediatr Infect Dis 3 1984 467-486
30. Hallander H.O. Storsaeter J. Molby R. Evaluation of serology and nasopharyngeal cultures for diagnosis of pertussis in a vaccine efficacy trial J Infect Dis 163 1991 1046-1086
31. Garcia-Corbeira P. Dal-Re R. Aguilar L. Garcia-de-Lomas J. Seroepidemiology or Bordetella pertussis infections in the Spanish population: a cross-sectional study Vaccine 18 21 2000 2173-2176
32. Consejeria de Salud. Dirección General de Prevención y Promoción de la Salud. Comunidad de Madrid. Informe: Encuesta de serovigilancia. Bol Epidemiol Communidad de Madrid 1995:4:3-28
33. Eiros J.M. Ortiz de Lejarazu R. Orduña Domingo A. Bachiller Luque M.R. Estudio seroepidemiológico en niños vacunados frente a la tos ferina An Esp Pediatr 41 1994 285-286
34. a Encuesta Seroepidemiologica de Castilla y Leon, 1996:5-63
35. Domínguez A. Vidal J. Plans P. Salleras L. The seroepidemiology of B. pertussis infection in Catalonia, Spain Epidemiol Infect 126 2001 205-210
36. Keitel W.A. Edwards K.M. Pertussis in adolescents and adults: time to reimmunize? Sem Respir Infect 10 1995 51-57
37. Novelli V. Al-Ansari H. Mok Q. Tasker R. Pertussis vaccination: is there a need for a booster dose? Lancet 344 1994 1225-1226
38. Miller E. White J.M. Fairley C.K. Pertussis vaccination Lancet 344 1994 1575-1576